Recurrent Breast Cancer Completed Phase Trials for Anastrozole (DB01217)

Also known as: Breast Cancer Recurrent / Breast cancer NOS recurrent / Carcinoma breast recurrent / Breast carcinoma recurrent / Breast carcinoma NOS recurrent

IndicationStatusPhase
DBCOND0028640 (Recurrent Breast Cancer)CompletedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01153672Vorinostat in Treating Patients With Stage IV Breast Cancer Receiving Aromatase Inhibitor TherapyTreatment